CNS Pharmaceuticals’ Directors Take a Bet on Their Own Stock as Shares Plunge 13% This Week
Insider buying shows confidence in CNS Pharmaceuticals amid a steep 13% weekly drop – learn why execs are buying shares and what it means for investors.
2 minutes to read